Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
06 Septiembre 2023 - 3:01PM
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company
pioneering a novel technology for bioengineering fully
transplantable organs to help save and improve patients' lives,
announced its participation in the H.C. Wainwright
Annual Global Investment Conference on September 11th,
2023.
Miromatrix Medical’s management is scheduled to present at the
H.C. Wainwright Annual Global Investment Conference.
Interested parties can access the webcast beginning Monday,
September 11, 2023, at 7am ET, here.
About MiromatrixMiromatrix Medical Inc. is
a life sciences company pioneering a novel technology for
bioengineering fully transplantable human organs to help save and
improve patients' lives. The Company has developed a proprietary
perfusion technology platform for bioengineering organs that it
believes will efficiently scale to address the shortage of
available human organs. The Company's initial development focus is
on human livers and kidneys. For more information,
visit miromatrix.com.
Investor ContactGreg Chodaczek347-620-7010
ir@miromatrix.com
Media Contact:Christina
Campbell612-924-3793Christina@media-minefield.com
MiroMatrix Medical (NASDAQ:MIRO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
MiroMatrix Medical (NASDAQ:MIRO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
